Home > Quotes > VRTX > Company News
VRTX

Vertex Pharmaceuticals Incorporated News Headlines

$79.49
*  
1.60
  negative  
2.05%
Get VRTX Alerts
*Delayed - data as of May 17, 2013 
Exchange: NASDAQ
Industry: Consumer Durables
Community Rating:
 
 

Symbol List Views

Stock Details

CHARTS

COMPANY NEWS

STOCK ANALYSIS

FUNDAMENTALS

HOLDINGS

Edit Symbol List
Enter up to 25 symbols separated by commas or spaces in the text box below. These symbols will be available during your session for use on applicable pages.


Don't know the stock symbol? Use the symbol lookup tool.

Alphabetize the sort order of my symbols 
Symbol Lookup
Log in or Register
 Save stocks for next time
 | Sponsored
Viewing
Filtered By
Ordered By

Safest Way to Play Biotech - Cook`s Kitchen
1/25/2013 4:54:01 AM - Zacks.com

Why You Should Sell Vertex
1/21/2013 11:21:00 AM - Seeking Alpha

UDR Is Trading At A Discount With A Strong Case For Growth
1/16/2013 8:53:00 PM - Seeking Alpha

Will 2013 Be A Better Year For Zalicus?
1/10/2013 1:58:00 PM - Seeking Alpha

Vertex attracts unusual time strategy
1/10/2013 4:14:48 AM - optionMONSTER

Achillion: Poised For Growth And Now Is The Time To Buy
1/2/2013 6:11:00 AM - Seeking Alpha

Danger Zone: iShares S&P MidCap 400 Growth Index Fund (IJK)
12/31/2012 12:14:00 PM - Seeking Alpha

Weekly Guru Bargains Highlights: MBI, VRTX, GRPN, PBI, PC
12/16/2012 12:38:37 PM - GuruFocus

Canada Approves Vertex's Kalydeco - Analyst Blog
12/10/2012 12:10:01 PM - Zacks.com

Kalydeco Approval In Canada More Important To Patients Than To Vertex
12/3/2012 2:34:00 PM - Seeking Alpha

Lessons From The Liver Meeting: Sagient's John Tucker Names Companies That Could Reignite The Hepatitis C Industry
11/30/2012 7:08:00 AM - Seeking Alpha

Is Gilead Sciences Still A Good Buy?
11/28/2012 1:09:00 PM - Seeking Alpha

The 12 Most Oversold Mid-Caps
11/26/2012 10:47:00 AM - Seeking Alpha

Pessimism On Vertex Pharmaceuticals Increases, Erasing Previous Gains
11/16/2012 7:22:00 AM - Seeking Alpha

Market Close Report: NASDAQ Composite index closes at 2,836.94 down -9.87 points
11/15/2012 5:45:13 PM - NASDAQ.com News

Hep C Competitors Cede Space To Gilead And Bristol-Myers And Turn To Niche Uses
11/12/2012 2:34:00 PM - Seeking Alpha

5 Healthcare Companies With Insider Buying During November 2012 - Part III
11/9/2012 4:41:00 PM - Seeking Alpha

For Biotech Investors: 5 Orphan Drugs And Their Parent Companies
11/8/2012 4:38:00 PM - Seeking Alpha

Disappointing Quarter from Vertex - Analyst Blog
11/5/2012 12:20:01 PM - Zacks.com

Biotech Weekend Recap: Earnings Reports
11/5/2012 4:26:00 AM - Seeking Alpha

Why I'm Going Long 1 Biotech And Short Another: Earnings
11/5/2012 2:48:00 AM - Seeking Alpha

Market Close Report: NASDAQ Composite index closes at 2,982.13 down -37.93 points
11/2/2012 4:45:10 PM - NASDAQ.com News

Benzinga Mid-Morning Market Update
11/2/2012 10:54:39 AM - Benzinga

Thursday Options Brief: RIMM, VRTX & ABX
11/1/2012 1:27:00 PM - Seeking Alpha

Buy Gilead Sciences: HIV And Hepatitis Drugs To Drive Growth
10/25/2012 6:22:00 AM - Seeking Alpha